These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1514679)

  • 1. High-performance liquid chromatography determination of polydeoxyribonucleotides in plasma: its application to the determination of defibrotide's pharmacokinetics in the rabbit.
    Porta R; Moltrasio D; Pescador R; Lanzarotti E; Mantovani M; Prino G
    Anal Biochem; 1992 Jul; 204(1):143-6. PubMed ID: 1514679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption through the peritoneum of the macromolecular profibrinolytic drug defibrotide in the rabbit.
    Porta R; Calvani AB; Pescador R; Mantovani M; Prino G
    Semin Thromb Hemost; 1991 Oct; 17(4):404-6. PubMed ID: 1803509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of defibrotide in healthy volunteers.
    Noseda G; Fragiacomo C; Ferrari D
    Haemostasis; 1986; 16 Suppl 1():26-30. PubMed ID: 3754833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of Defibrotide and of its profibrinolytic activity in the rabbit.
    Pescador R; Mantovani M; Prino G; Madonna M
    Thromb Res; 1983 Apr; 30(1):1-11. PubMed ID: 6687960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defibrotide is antithrombotic and thrombolytic against rabbit venous thrombosis.
    Niada R; Pescador R; Porta R; Mantovani M; Prino G
    Haemostasis; 1986; 16 Suppl 1():3-8. PubMed ID: 3519381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on pharmacokinetics of radioactive labelled defibrotide after oral or intravenous administration in rats.
    Fisher J; Holland TK; Pescador R; Porta R; Ferro L
    Thromb Res; 1996 Jan; 81(1):55-63. PubMed ID: 8747520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defibrotide's activity on leukocytes and platelets in rabbits with diet-induced atherosclerosis.
    Pescador R; Tettamanti R; Salvetti L; Conto A; Porta R; Mantovani M; Ferro L
    Agents Actions Suppl; 1995; 45():323-7. PubMed ID: 7717197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the pharmacokinetics and determination of tramadol in rabbit plasma by a high-performance liquid chromatography-diode array detector method using liquid-liquid extraction.
    Küçük A; Kadioğlu Y; Celebi F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):203-8. PubMed ID: 15664351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Safety of Defibrotide in Healthy Japanese Subjects.
    Umemura K; Iwaki T; Kimura T; Ogawa C; Fukuda T; Taniguchi S; Horibe K; Goto H; Yoshimura K; Watanabe Y; Nitani C; Kikuta A
    Clin Pharmacol Drug Dev; 2016 Nov; 5(6):548-551. PubMed ID: 27870480
    [No Abstract]   [Full Text] [Related]  

  • 10. Defibrotide: an overview of clinical pharmacology and early clinical studies.
    Cornelli U; Nazzari M
    Semin Thromb Hemost; 1988; 14 Suppl():64-70. PubMed ID: 3057638
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies.
    Bhatta RS; Kumar D; Chhonker YS; Saxena AK; Jain GK
    Biomed Chromatogr; 2010 Nov; 24(11):1234-9. PubMed ID: 20954216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of defibrotide against myocardial ischemia and decline of beta-adrenoceptor function in the rabbit.
    Berti F; Rossoni G; Niada R; Omini C; Pretolani M; Mandelli C
    Haemostasis; 1986; 16 Suppl 1():13-7. PubMed ID: 3011616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effects of defibrotide in acute lethal and nonlethal myocardial ischemia in the cat.
    Niada R; Porta R; Pescador R; Mantovani M; Prino G; Berti F
    Haemostasis; 1986; 16 Suppl 1():18-25. PubMed ID: 3519380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile of defibrotide in patients with renal impairment.
    Tocchetti P; Tudone E; Marier JF; Marbury TC; Zomorodi K; Eller M
    Drug Des Devel Ther; 2016; 10():2631-41. PubMed ID: 27574402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is defibrotide's activity on leukocytes adenosine-receptor mediated? An "in vitro"--"ex vivo" appraisal.
    Alberico P; Porta R; Pescador R; Ferro L
    Thromb Res; 1995 Nov; 80(4):281-9. PubMed ID: 8585040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of 3H-defibrotide with cultured human umbilical vein endothelial cells.
    Bilsel S; Yalçin AS; Taga Y; Emerk K
    Thromb Res; 1990 Jun; 58(5):455-60. PubMed ID: 2368032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrotide in extracorporeal circulation on healthy rabbits.
    Marsili M; Lorenzi P; Librenti M; Doni L; Benassai C; Martini E; Fabbri LP; Cinotti S; Morfini M; Boncinelli S
    Int J Artif Organs; 1989 Dec; 12(12):749-54. PubMed ID: 2613355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric and ultrastructural study of experimental venous thrombosis. Effects of defibrotide, an antithrombotic agent.
    Fumagalli G; Angelaccio E; Lombardo N; Clementi F
    Haemostasis; 1987; 17(6):361-70. PubMed ID: 3428723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an indirect competitive ELISA for quantification of recombinant staphylokinase in rabbit plasma: Application to pharmacokinetic study.
    Kumar A; Pulicherla KK; Sambasiva Rao KR
    J Immunoassay Immunochem; 2016; 37(3):228-42. PubMed ID: 26674740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.